Document Type: Case Report


Dept. of Periodontics, K.L.E Society’s Institute of Dental Sciences, Bengaluru, Karnataka, India.


The treatment of gingival recession is a frequent demand due to aesthetic concern, root caries, and /or root hypersensitivity. The purpose of this case study was to evaluate the success and predictability of coronally advanced flap (CAF) in combination with peripheral blood mesenchymal stem cells (PBMSCs) and platelet rich fibrin matrix(PRFM) for the management of Miller's Class II gingival recession. CAF followed by placement of PBMSCs and PRFM was performed on a male patient, aged 25 years having Miller’s Class II gingival recession of 5-6 mm on the upper left canine, premolars and molars. The patient was followed up for 3 months. Root coverage of 60.0% and clinical attachment gain of 3 mm were evident following 3 months of follow-up. This novel technique showed an effective way to increase the width of attached gingiva and treat gingival recession.


[1]  Alghamdi HBabay NSukumaran A. Surgical management of gingival recession: A clinical updateSaudi Dent J. 2009; 21: 83-94.

[2]  Cortellini P, Pini*Prato G. Coronally advanced flap and combination therapy for root coverage. Clinical strategies based on scientific evidence and clinical experience. Periodontol 2000. 2012; 59: 158-184. 

[3]  Shkreta M, Atanasovska-Stojanovska A, Dollaku B, Belazelkoska Z. Exploring the gingival recession surgical treatment modalities: A literature review. J Med Sci. 2018; 6: 698-708.

[4]  Kökdere NN, Baykul T, Findik Y. The use of platelet-rich fibrin (PRF) and PRF-mixed particulated autogenous bone graft in the treatment of bone defects: An experimental and histomorphometrical study. Dent Res J. 2015; 12: 418-424.  

[5]  Miron RJ, Fujioka-Kobayashi M, Bishara M, Zhang Y, Hernandez M, Choukroun J. Platelet-rich fibrin and soft tissue wound healing: a systematic review. Tissue Eng Part B Rev. 2017; 23: 83–99.

[6]  Simonpieri A, Del*Corso M, Vervelle A, Jimbo R, Inchingolo F, Sammartino G, et al. Current knowledge and perspectives for the use of platelet rich plasma (PRP) and Platelet rich fibrin (PRF) in oral and maxillofacial surgery part 2: Bone graft, implant and reconstructive surgery. Curr Pharm Biotechnol 2012; 13: 1231-1256.

[7]  Roy S, Driggs J, Elgharably H, Biswas S, Findley M, Khanna S, et al. Platelet-rich fibrin matrix improves wound angiogenesis via inducing endothelial cell proliferation. Euro Tissue Repair Soc. 2012; 19: 753-766.

[8]  Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015; 35: e00191.

[9]  Guofeng W, Mengjie P, Xianghai W, Jinkun W, Shangtao C, Zhenlin L, et al. Osteogenesis of peripheral blood mesenchymal stem cells in self assembling peptide nanofiber for healing critical size calvarial bony defect. Sci Rep. 2015; 5: 16681.

[10]         Prakash S, Thakur A. Platelet concentrates: past, present and future. J Maxillofac Oral Surg. 2011; 10: 45-49.

[11]         Agrawal AA. Evolution, current status and advances in application of platelet concentrate in periodontics and implantology. World J Clin Cases. 2017; 5: 159-171.

[12]         Li S, Huang KJ, Wu JC, Hu MS, Sanyal M, Hu M, et al. Peripheral blood-derived mesenchymal stem cells: candidate cells responsible for healing critical-sized calvarial bone defects. Stem Cells Transl Med. 2015; 4: 359-368.

[13]         Chandran P, Sivadas A. Platelet-rich fibrin: Its role in periodontal regeneration. The Saud J Dent Res. 2013;5:117-122.